Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

13.76
Delayed Data
As of Apr 24
 -0.18 / -1.29%
Today’s Change
7.09
Today|||52-Week Range
14.07
+65.78%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close13.94
Today’s open13.97
Day’s range13.66 - 14.07
Volume295,846
Average volume (3 months)568,635
Market cap$643.7M
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-62.50%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+915.43%
P/E ratio35.0
Price/Sales2.87
Price/Book8.29

Competitors

 Today’s
change
Today’s
% change
ADXSAdvaxis Inc-0.27-1.14%
TBPHTheravance Biopharma...+0.06+0.33%
DVAXDynavax Technologies...-0.38-1.60%
FLMLFlamel Technologies ...+0.02+0.13%
Data as of 4:00pm ET, 04/24/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$122.0M
Annual profit (last year)$19.9M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers